0000920465-19-000009.txt : 20190109
0000920465-19-000009.hdr.sgml : 20190109
20190109212848
ACCESSION NUMBER: 0000920465-19-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190109
FILED AS OF DATE: 20190109
DATE AS OF CHANGE: 20190109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rolke James
CENTRAL INDEX KEY: 0001693858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 19519165
MAIL ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_154708731010561.xml
FORM 4
X0306
4
2019-01-09
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001693858
Rolke James
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2019-01-09
4
P
0
300
6.07
A
75030
D
Common Stock
2019-01-09
4
P
0
500
6.09
A
75530
D
Common Stock
2019-01-09
4
P
0
800
6.10
A
76330
D
/s/ Ryan Murr, as attorney-in-fact for James M. Rolke
2019-01-09